• Search

  • Post Date

  • Categories

  • Contributors

Anal Cancer in HIV Positive MSMs

By Robert Castro, MD

May 6th, 2016

Dr. Castro reviews the epidemiology of anal squamous cell carcinoma, a significant malignancy in HIV positive men who have sex with men (MSMs). He also reviews risk factors, classification systems, the disease’s association with Human Papilloma Virus (HPV), screening strategies, and management after diagnosis

Infections Associated with Freshwater and Saltwater Exposure

By Shuchi Pandya, MD

April 25th, 2016

The specific infections associated with aquatic activity are reviewed and explored. Examples include Vibrio vulnificus, Mycobacterium marinum, Plesiomonas, Aeromonas, Cnidarial Seabather’s eruption, Lobomycosis, and others. Risk factors, clinical manifestations, and treatment are also reviewed.

Top Ten Lesser Known Contemporary Outbreaks

By Richard L. Oehler, MD

February 23rd, 2016

In a question and answer format, Dr. Oehler covers 10 recent outbreaks that are lesser known, either because of their regional nature, small number of cases, or simply because they lack a well-known champion. Examples of these include the Heartland virus, Australian Bat Lyssavirus, and Enterovirus 068.

Zika and Emerging Arboviruses in the Americas

By Sandra Gompf, MD, FACP

February 18th, 2016

Dr. Sandra Gompf highlights the recent emergence of several mosquito-borne arboviruses in the Caribbean and South American continent, including Dengue virus, Chikungunya, and Zika virus. In particular, she examines Zika and the factors responsible for its development on our continent. Dr. Gompf also discusses Zika epidemiology, risk factors, clinical manifestations, treatment, and prevention.

Cholera

By Manuel Castro, MD

February 1st, 2016

In this informative presentation, Dr. Manuel Castro discusses the epidemiology, clinical features, and management of Cholera infections. Dr. Castro also discusses the factors behind recent worldwide cholera outbreaks, such as the cholera outbreak occurring after the 2010 Haitian earthquake.

Invasive Fungal Infections in the Immunocompromised Host

By Aliyah Baluch, MD, Msc

November 3rd, 2015

Dr. Aliyah Baluch focuses on the work-up and treatment of invasive fungal infections in the immunosuppressed patients. Fungal infections have high morbidity and mortality, but can be hard to clinically diagnose. Invasive infections occur in ICU, Diabetes Mellitus, and immunocompromised patients. Dr. Baluch covers both aspects of Candida and non-Candida species infections, including risk factors, symptoms, prognosis, work-up, and treatment in patients with immunosuppressed patients. She includes a review of fungal structure and the mechanism of action of the drug classes used to treat them – Echinocandins, Polyenes, and Triazoles. She covers timelines that indicate which species to expect during each stage of immunosuppression and with different mechanisms of immunosuppression, including differences between stem cell and solid organ transplants. Biomarkers for treatment and international patterns of drug resistance are also discussed.

Overview of Bone and Joint Infections

By Yanina Pasikhova, Pharm.D.

October 17th, 2015

Yanina Pasikhova, clinical pharmacist at Moffitt Cancer Center, presents this talk about bone and joint infections – osteomyelitis, septic arthritis, prosthetic joint infection. Ms. Pasikhova goes over case studies while focusing on different organisms expected in acute vs. chronic infections, route of infections, indications for empiric treatment, and work-up for infections. Infections can occur via hematogenous spread due to risk factors like IV Drug Use, hemodialysis, or immunocompromise, or contiguous from surgery, open fractures, burns, and soft tissue infections. She discusses diagnostics, including best practices for cultures, and indications for imaging studies. Finally, she discusses treatment – while there are no official guidelines for Osteomyelitis, but historically IV antibiotics are used. She reviews the literature which compares oral and IV antibiotics and which antibiotics should be used for different infections.